Literature DB >> 10369603

Ocular inflammation associated with alendronate therapy.

J N Mbekeani1, T L Slamovits, B H Schwartz, H L Sauer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10369603

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


× No keyword cloud information.
  15 in total

1.  Bilateral acute anterior uveitis after alendronate.

Authors:  A R Malik; S H Campbell; N M G Toma
Journal:  Br J Ophthalmol       Date:  2002-12       Impact factor: 4.638

Review 2.  Ocular side effects of bisphosphonates: A case report and literature review.

Authors:  Meredith McKague; Derek Jorgenson; Kelly A Buxton
Journal:  Can Fam Physician       Date:  2010-10       Impact factor: 3.275

Review 3.  Ocular adverse effects associated with systemic medications : recognition and management.

Authors:  Ricardo M Santaella; Frederick W Fraunfelder
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 4.  Diffuse ocular and orbital inflammation after zoledronate infusion-case report and review of the literature.

Authors:  Obi C Umunakwe; David Herren; Stephen J Kim; Sahar Kohanim
Journal:  Digit J Ophthalmol       Date:  2017-12-28

5.  Inflammatory ocular adverse events with the use of oral bisphosphonates: a retrospective cohort study.

Authors:  Mahyar Etminan; Farzin Forooghian; David Maberley
Journal:  CMAJ       Date:  2012-04-02       Impact factor: 8.262

Review 6.  Chronic non-infectious uveitis in the elderly: epidemiology, pathophysiology and management.

Authors:  Rajen Gupta; Philip I Murray
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

7.  Prescription-event monitoring study on 13,164 patients prescribed risedronate in primary care in England.

Authors:  Beate Aurich Barrera; Lynda Wilton; Scott Harris; Saad A W Shakir
Journal:  Osteoporos Int       Date:  2005-08-31       Impact factor: 4.507

8.  Ophthalmological events in patients receiving risedronate: summary of information gained through follow-up in a prescription-event monitoring study in England.

Authors:  Beate Aurich-Barrera; Lynda Wilton; Scott Harris; Saad A W Shakir
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

9.  Unilateral anterior uveitis complicating zoledronic acid therapy in breast cancer.

Authors:  Nagi S El Saghir; Zaher K Otrock; Jamal H Bleik
Journal:  BMC Cancer       Date:  2005-12-06       Impact factor: 4.430

10.  Drug-induced uveitis.

Authors:  Nikolas Js London; Sunir J Garg; Ramana S Moorthy; Emmett T Cunningham
Journal:  J Ophthalmic Inflamm Infect       Date:  2013-03-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.